Matthew J Gutierrez, MD | |
246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301-2548 | |
(603) 224-6070 | |
(603) 224-6094 |
Full Name | Matthew J Gutierrez |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 27 Years |
Location | 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508860552 | NPI | - | NPPES |
101073612 | Medicaid | PA |
Facility Name | Location | Facility Type |
---|---|---|
Concord Hospital | Concord, NH | Hospital |
Lakes Region General Hospital | Laconia, NH | Hospital |
Speare Memorial Hospital | Plymouth, NH | Hospital |
Franklin Regional Hospital | Franklin, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Concord Hospital Inc | 6103721790 | 462 |
News Archive
The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.
Earlier diagnosis of people with cancer could save between 5,000 and 10,000 lives each year, Professor Mike Richards, the National Cancer Director for England, has claimed.
Scientists in the United States suggest a blood test widely used to screen for prostate cancer can be misleading in the case of men who are obese.
Redilearning, the largest provider of learning solutions focused exclusively on the senior care industry, today announced a partnership with Skillsoft, a global leader and pioneer in the field of learning, that empowers providers to grow their workforce to unprecedented levels of performance. As part of the agreement, Redilearning will offer learning programs that further extend and emphasize its dedication to the senior care industry.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced enrollment of the first patient in a global Phase IIIb, randomized, rater-blinded, active-controlled study designed to evaluate switching to TYSABRI® (natalizumab) from Copaxone® (glatiramer acetate) or Rebif® (interferon beta-1a) in patients with relapsing remitting multiple sclerosis.
› Verified 4 days ago
Entity Name | Concord Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.
Earlier diagnosis of people with cancer could save between 5,000 and 10,000 lives each year, Professor Mike Richards, the National Cancer Director for England, has claimed.
Scientists in the United States suggest a blood test widely used to screen for prostate cancer can be misleading in the case of men who are obese.
Redilearning, the largest provider of learning solutions focused exclusively on the senior care industry, today announced a partnership with Skillsoft, a global leader and pioneer in the field of learning, that empowers providers to grow their workforce to unprecedented levels of performance. As part of the agreement, Redilearning will offer learning programs that further extend and emphasize its dedication to the senior care industry.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced enrollment of the first patient in a global Phase IIIb, randomized, rater-blinded, active-controlled study designed to evaluate switching to TYSABRI® (natalizumab) from Copaxone® (glatiramer acetate) or Rebif® (interferon beta-1a) in patients with relapsing remitting multiple sclerosis.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew J Gutierrez, MD 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301-2548 Ph: (603) 224-6070 | Matthew J Gutierrez, MD 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301-2548 Ph: (603) 224-6070 |
News Archive
The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.
Earlier diagnosis of people with cancer could save between 5,000 and 10,000 lives each year, Professor Mike Richards, the National Cancer Director for England, has claimed.
Scientists in the United States suggest a blood test widely used to screen for prostate cancer can be misleading in the case of men who are obese.
Redilearning, the largest provider of learning solutions focused exclusively on the senior care industry, today announced a partnership with Skillsoft, a global leader and pioneer in the field of learning, that empowers providers to grow their workforce to unprecedented levels of performance. As part of the agreement, Redilearning will offer learning programs that further extend and emphasize its dedication to the senior care industry.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced enrollment of the first patient in a global Phase IIIb, randomized, rater-blinded, active-controlled study designed to evaluate switching to TYSABRI® (natalizumab) from Copaxone® (glatiramer acetate) or Rebif® (interferon beta-1a) in patients with relapsing remitting multiple sclerosis.
› Verified 4 days ago
Patrick Cassell, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6994 | |
Dr. Michael A Ferguson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Clayton Theron Jones, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. David Scott Johnson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Primary Care, Concord, NH 03301 Phone: 603-226-2200 | |
Frederick M Briccetti, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant Street, New Hampshire Oncology Hematology Pa, Concord, NH 03301 Phone: 603-224-2556 Fax: 603-226-5821 | |
Dr. Patrick Magnus, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Celia Ann Englander, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 281 N State St, Concord, NH 03301 Phone: 603-271-6064 |